# Invesco DB Base Metals Fund: financial statements, quarterly

DBB · NYSE · CIK 1383084 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dbb.md) · [Financials](/companies/dbb/financials.md) · [Filings](/companies/dbb/filings.md) · [Insiders](/companies/dbb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dbb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [2.0](/filings/0000950170-24-122591.md) | [1.7 d](/filings/0001193125-26-083547.md) | [1.4](/filings/0000950170-25-067200.md) | [1.7](/filings/0000950170-25-105190.md) | [1.4](/filings/0001193125-25-270324.md) | [1.3 d](/filings/0001193125-26-083547.md) | [1.0](/filings/0001193125-26-209734.md) | [1.0](/filings/0001193125-26-338712.md) | [1.0](/filings/0001193125-25-270324.md) | [1.0 d](/filings/0001193125-26-083547.md) | [1.8](/filings/0001193125-26-209734.md) | [2.4](/filings/0001193125-26-338712.md) |
| Interest expense | $m | [0.0](/filings/0000950170-24-122591.md) | [0.0 d](/filings/0000950170-24-019050.md) | [0.0](/filings/0000950170-24-054952.md) | [0.0](/filings/0000950170-24-092110.md) | [0.0](/filings/0000950170-24-122591.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [10.1](/filings/0000950170-24-122591.md) | [2.4 d](/filings/0001193125-26-083547.md) | [(2.2)](/filings/0000950170-25-067200.md) | [14.6](/filings/0000950170-25-105190.md) | [2.0](/filings/0001193125-25-270324.md) | [(6.9) d](/filings/0001193125-26-083547.md) | [2.1](/filings/0001193125-26-209734.md) | [(0.0)](/filings/0001193125-26-338712.md) | [6.9](/filings/0001193125-25-270324.md) | [21.6 d](/filings/0001193125-26-083547.md) | [0.5](/filings/0001193125-26-209734.md) | [4.6](/filings/0001193125-26-338712.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-083547.md) | not reported | not reported | not reported | [3.5](/filings/0001193125-26-338712.md) | [0.0](/filings/0001193125-26-209734.md) | [6.0](/filings/0001193125-26-338712.md) |
| Total assets | $m | [160](/filings/0000950170-23-060459.md) | [127](/filings/0000950170-25-027245.md) | [125](/filings/0000950170-24-054952.md) | [171](/filings/0000950170-24-092110.md) | [127](/filings/0000950170-24-122591.md) | [119](/filings/0001193125-26-083547.md) | [127](/filings/0000950170-25-067200.md) | [118](/filings/0000950170-25-105190.md) | [126](/filings/0001193125-25-270324.md) | [203](/filings/0001193125-26-338712.md) | [299](/filings/0001193125-26-209734.md) | [365](/filings/0001193125-26-338712.md) |
| Total liabilities | $m | [6.6](/filings/0000950170-23-060459.md) | [5.5](/filings/0000950170-25-027245.md) | [6.6](/filings/0000950170-24-054952.md) | [1.2](/filings/0000950170-24-092110.md) | [0.3](/filings/0000950170-24-122591.md) | [5.9](/filings/0001193125-26-083547.md) | [2.9](/filings/0000950170-25-067200.md) | [1.0](/filings/0000950170-25-105190.md) | [0.1](/filings/0001193125-25-270324.md) | [0.3](/filings/0001193125-26-338712.md) | [8.0](/filings/0001193125-26-209734.md) | [17.1](/filings/0001193125-26-338712.md) |
| Shareholders' equity | $m | [153](/filings/0000950170-24-122591.md) | [122](/filings/0001193125-26-083547.md) | [118](/filings/0000950170-25-105190.md) | [169](/filings/0001193125-25-270324.md) | [127](/filings/0001193125-25-270324.md) | [113](/filings/0001193125-26-338712.md) | [124](/filings/0001193125-26-338712.md) | [117](/filings/0001193125-26-338712.md) | [126](/filings/0001193125-25-270324.md) | [203](/filings/0001193125-26-338712.md) | [291](/filings/0001193125-26-338712.md) | [348](/filings/0001193125-26-338712.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [23.1 d](/filings/0000950170-24-122591.md) | [33.5 d](/filings/0001193125-26-083547.md) | [1.3](/filings/0000950170-25-067200.md) | [(36.3) d](/filings/0000950170-25-105190.md) | [44.4 d](/filings/0001193125-25-270324.md) | [7.3 d](/filings/0001193125-26-083547.md) | [(8.9)](/filings/0001193125-26-209734.md) | [6.7 d](/filings/0001193125-26-338712.md) | [(2.0) d](/filings/0001193125-25-270324.md) | [(51.4) d](/filings/0001193125-26-083547.md) | [(94.7)](/filings/0001193125-26-209734.md) | [(52.7) d](/filings/0001193125-26-338712.md) |
| Dividends paid | $m | not reported | not reported | [0.4](/filings/0000950170-25-067200.md) | [0.0 d](/filings/0000950170-25-105190.md) | [0.0 d](/filings/0001193125-25-270324.md) | [5.4 d](/filings/0001193125-26-083547.md) | not reported | not reported | not reported | [4.9 d](/filings/0001193125-26-083547.md) | not reported | not reported |
| Share repurchases | $m | [24.0 d](/filings/0000950170-24-122591.md) | [51.4 d](/filings/0001193125-26-083547.md) | [4.4](/filings/0000950170-25-067200.md) | [42.8 d](/filings/0000950170-25-105190.md) | [53.0 d](/filings/0001193125-25-270324.md) | [53.8 d](/filings/0001193125-26-083547.md) | [6.6](/filings/0001193125-26-209734.md) | [16.2 d](/filings/0001193125-26-338712.md) | [11.7 d](/filings/0001193125-25-270324.md) | [24.6 d](/filings/0001193125-26-083547.md) | [49.5](/filings/0001193125-26-209734.md) | [54.9 d](/filings/0001193125-26-338712.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 14,450,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338712.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.